Surgical Aesthetics was Apyx Medical’s largest segment in fiscal 2025, bringing in $45.33M of $52.84M (86%).
| Segment | FY 2010 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics | — | — | $38.61M | $45.33M | |||||||||||
| Reportable Segment One | — | — | — | — | |||||||||||
| Core | — | — | — | — | |||||||||||
| Advanced Energy | $36.80M | $43.38M | — | — | |||||||||||
| Oem | $7.71M | $8.97M | $9.50M | $7.51M | |||||||||||
| J-Plasma | — | — | — | — | |||||||||||
| J-Plas Ma | — | — | — | — | |||||||||||
| Reportable Segment Two | — | — | — | — | |||||||||||
| Total | $44.51M | $52.35M | $48.10M | $52.84M |
Apyx Medical brought in $52.84M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 9.9% from $48.10M in fiscal 2024. Surgical Aesthetics was the largest at $45.33M (85.8%), ahead of Oem at $7.51M (14.2%).
Compared with fiscal 2024, Surgical Aesthetics grew 17.4% to $45.33M, while Oem fell 20.9% to $7.51M.
Apyx Medical began breaking out Surgical Aesthetics in fiscal 2024, when it brought in $38.61M. Apyx Medical stopped reporting Advanced Energy as a separate segment after fiscal 2023, when it brought in $43.38M.
United States was Apyx Medical’s largest region in fiscal 2025, bringing in $38.80M of $52.84M (73%).
| Geography | FY 2014 | FY 2015 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | — | $38.35M | $34.02M | $38.80M | |||||||
| Domestic | $31.21M | — | — | — | |||||||
| Non-Us | — | $14.00M | $14.08M | $14.04M | |||||||
| International | $13.30M | — | — | — | |||||||
| Total | $44.51M | $52.35M | $48.10M | $52.84M |
Apyx Medical brought in $52.84M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 9.9% from $48.10M in fiscal 2024. United States was the largest at $38.80M (73.4%), ahead of Non-Us at $14.04M (26.6%).
Compared with fiscal 2024, United States grew 14.0% to $38.80M, while Non-Us fell 0.3% to $14.04M.
Apyx Medical began breaking out United States in fiscal 2023 and Non-Us in fiscal 2023. Apyx Medical stopped reporting Domestic ($31.21M in fiscal 2022) and International ($13.30M in fiscal 2022) as separate regions.
Electrosurgical was Apyx Medical’s largest revenue line in fiscal 2015, bringing in $17.56M of $29.52M (59%).
| Products and Services | FY 2014 | FY 2015 |
|---|---|---|
| Electrosurgical | $16.71M | $17.56M |
| Cauteries | $6.90M | $6.89M |
| Other | $4.08M | $2.60M |
| Lighting | — | $2.48M |
| Total | $27.68M | $29.52M |
Apyx Medical brought in $29.52M from its four revenue lines in fiscal 2015, the year ended December 31, 2015. Apyx Medical regrouped these revenue lines after fiscal 2014, so the total does not compare directly with that year's $27.68M. Electrosurgical was the largest at $17.56M (59.5%), ahead of Cauteries at $6.89M (23.3%) and Other at $2.60M (8.8%). The remaining revenue line, Lighting, brought in $2.48M.
Compared with fiscal 2014, Electrosurgical grew fastest, up 5.1% to $17.56M, while Other fell the most, down 36.3% to $2.60M.
Apyx Medical began breaking out Lighting in fiscal 2015, when it brought in $2.48M.
Apyx Medical (APYX) reports its revenue by segment, by geography and by products and services. In fiscal 2025, Surgical Aesthetics was its largest segment, bringing in $45.33M (85.8% of the total), followed by Oem at $7.51M (14.2%).
Surgical Aesthetics was Apyx Medical's largest segment in fiscal 2025, bringing in $45.33M, or 85.8% of the $52.84M total across its two segments.
United States was Apyx Medical's largest region in fiscal 2025, bringing in $38.80M, or 73.4% of the $52.84M total across its two regions.
Electrosurgical was Apyx Medical's largest revenue line in fiscal 2015, bringing in $17.56M, or 59.5% of the $29.52M total across its four revenue lines.
Surgical Aesthetics grew faster than Oem in fiscal 2025, up 17.4% from $38.61M to $45.33M. Oem fell 20.9% to $7.51M.
Every figure comes from Apyx Medical's annual financial filings, as reported. Each line keeps the name Apyx Medical gives it, and years follow its fiscal calendar.
Apyx Medical's revenue by segment goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.